The Role of Amivantamab Plus Lazertinib in EGFR NSCLC | OncLive
The Role of Amivantamab Plus Lazertinib in EGFR NSCLC | OncLive
1 month ago
onclive.com
Amivantamab in NSCLC: Interpreting MARIPOSA and Guideline Placement | Pharmacy Times
3:22
Amivantamab in NSCLC: Interpreting MARIPOSA and Guide…
1 week ago
pharmacytimes.com
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC Management | OncLive
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCL…
1 week ago
onclive.com
FDA Approval of Subcutaneous Amivantamab Is Significant Step Forward in NSCLC: Martin Dietrich, MD, PhD | AJMC
FDA Approval of Subcutaneous Amivantamab Is Significant Step F…
2 months ago
ajmc.com
Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutations
Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Inserti…
44 viewsMay 1, 2024
vumedi.com
Dr Sabari on the FDA Approval of Subcutaneous Amivantamab for EGFR-Mutant NSCLC | OncLive
Dr Sabari on the FDA Approval of Subcutaneous Amivantamab for E…
1 month ago
onclive.com
Treatment Options for EGFRm NSCLC: Amivantamab Lazertinib
Treatment Options for EGFRm NSCLC: Amivantamab Lazertinib
130 viewsFeb 21, 2025
vumedi.com
1:40
Dr Spira Details Future Directions for Amivantamab in NSCLC | OncL…
Jan 30, 2025
onclive.com
Optimizing Patient Selection and Treatment Management with Amiv…
Feb 19, 2025
onclive.com
Dr Joshua Sabari Discusses Amivantamab’s First-Line Approv…
Mar 4, 2024
ajmc.com
2:07
Dr Sabari on the FDA Approval of Frontline Amivantamab Plus Che…
Mar 29, 2024
onclive.com
EGFR Mutations in NSCLC: Clinical Use and Implications of Amivanta…
5 months ago
vumedi.com
Novel Mechanisms Set FDA-Approved Amivantamab-Lazertini…
Aug 30, 2024
ajmc.com
13:44
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Tre…
1 week ago
onclive.com
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
Nov 14, 2023
targetedonc.com
Dr Girard on the Efficacy of First-Line Amivantamab Plus Chemothe…
Oct 21, 2023
onclive.com
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
Dr. Marmarelis on the Efficacy of Lazertinib/Amivantamab Plus Che…
Aug 8, 2022
onclive.com
Amivantamab Toxicity Mitigation Strategies in the Treatment of EGF…
11 months ago
onclive.com
Dr Hassan on the CHRYSALIS trial of Amivantamab in EGFR Exon 20…
1 week ago
onclive.com
1:34
Dr Sabari on the FDA Approval of Amivantamab/Lazertinib in EGFR …
Sep 4, 2024
onclive.com
1:31
Dr Cho on Amivantamab Plus Lazertinib in Atypical EGFR-Mutat…
Jun 1, 2024
onclive.com
21:25
Amivantamab Plus Chemotherapy (With or Without Lazertinib) vs Ch…
Oct 31, 2023
onclive.com
Dr Leighl on Amivantamab in Advanced NSCLC With MET Exon …
Sep 12, 2023
onclive.com
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: …
275 viewsJul 19, 2021
vumedi.com
PAPILLON Study - Amivantamab Chemo vs. Chemo as 1L Treatmen…
854 viewsNov 17, 2023
vumedi.com
13:00
Amivantamab + Lazertinib Versus Osimertinib as 1L Treatment in EG…
2 weeks ago
onclive.com
3:48
Amivantamab Accolades Add Up for NSCLC | AJMC
Sep 27, 2024
ajmc.com
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mu…
Jun 19, 2024
onclive.com
3:38
Updates from PAPILLON: 1L Amivantamab Chemotherapy in A…
Nov 14, 2023
targetedonc.com
See more videos
Static thumbnail place holder